Kirk L. Somers - 05 Nov 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Signature
/s/ Kirk L. Somers
Issuer symbol
CDLX
Transactions as of
05 Nov 2021
Net transactions value
-$1,048,901
Form type
4
Filing time
08 Nov 2021, 16:24:31 UTC
Previous filing
06 Oct 2021
Next filing
13 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $269,940 -2,998 -7.3% $90.04 38,309 05 Nov 2021 Direct F1, F2
transaction CDLX Common Stock Sale $280,240 -3,100 -8.1% $90.40 35,209 05 Nov 2021 Direct F1, F3
transaction CDLX Common Stock Sale $27,465 -300 -0.85% $91.55 34,909 05 Nov 2021 Direct F1, F4
transaction CDLX Common Stock Sale $471,256 -5,070 -15% $92.95 29,839 05 Nov 2021 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for performance stock units that vested on October 6, 2021 and prior stock sales.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $89.34 to $90.335, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4) and (5) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $90.35 to $90.66, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $91.39 to $91.88, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.01, inclusive.